Compare · PETS vs YI
PETS vs YI
Side-by-side comparison of PetMed Express Inc. (PETS) and 111 Inc. (YI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PETS and YI operate in Retail-Drug Stores and Proprietary Stores (Consumer Staples), so they compete in similar markets.
- PETS is the larger of the two at $542.2M, about 1.2x YI ($466.6M).
- Over the past year, PETS is down 34.1% and YI is down 19.9% - YI leads by 14.2 points.
- YI has been more active in the news (2 items in the past 4 weeks vs 1 for PETS).
- PETS has more recent analyst coverage (6 ratings vs 0 for YI).
- Company
- PetMed Express Inc.
- 111 Inc.
- Price
- $2.28+2.70%
- $6.67+0.00%
- Market cap
- $542.2M
- $466.6M
- 1M return
- -2.98%
- +7.58%
- 1Y return
- -34.10%
- -19.88%
- Industry
- Retail-Drug Stores and Proprietary Stores
- Retail-Drug Stores and Proprietary Stores
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2018
- News (4w)
- 1
- 2
- Recent ratings
- 6
- 0
PetMed Express Inc.
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
111 Inc.
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; and Jianming Pharmaceutical Group. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Latest PETS
- PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
- SEC Form 10-Q filed by PetMed Express Inc.
- Director Fulgoni Gian returned 26,057 shares to the company, decreasing direct ownership by 16% to 132,299 units (SEC Form 4)
- PetMed Express Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Amendment: PetMed Express Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- SEC Form 10-Q filed by PetMed Express Inc.
- SEC Form 10-Q filed by PetMed Express Inc.
- Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express
- PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
- SEC Form DEF 14A filed by PetMed Express Inc.
Latest YI
- SEC Form 6-K filed by 111 Inc.
- 111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results
- SEC Form 3 filed by new insider Teo Nee Chuan
- SEC Form 3 filed by new insider Luo Jun Justin
- SEC Form 3 filed by new insider Sun Jian David
- SEC Form 3 filed by new insider Chen Yang Luke
- SEC Form 3 filed by 111 Inc.
- SEC Form 3 filed by 111 Inc.
- SEC Form 6-K filed by 111 Inc.
- 111, Inc. Announces Third Quarter 2025 Unaudited Financial Results